Literature DB >> 23563668

Neuronal forms of Gaucher disease.

Einat B Vitner1, Anthony H Futerman.   

Abstract

Gaucher disease is an inherited metabolic disease caused by the defective activity of the lysosomal enzyme, glucosylceramidase (GlcCerase), which is responsible for the last step in the degradation of complex glycosphingolipids. As a result, glucosylceramide (GlcCer) accumulates intracellularly. Little is known about the mechanisms by which GlcCer accumulation leads to Gaucher disease, particularly for the types of the disease in which severe neuropathology occurs. We now summarize recent advances in this area and in particular focus in the biochemical and cellular pathways that may cause neuronal defects. Most recent work has taken advantage of newly available mouse models, which mimic to a large extent human disease progression. Finally, we discuss observations of a genetic link between Gaucher disease and Parkinson's disease and discuss how this link has stimulated research into the basic biology of the previously underappreciated glycosphingolipid, GlcCer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563668     DOI: 10.1007/978-3-7091-1511-4_20

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  17 in total

1.  Theoretical investigations into the intermolecular hydrogen-bonding interactions of N-(hydroxymethyl)acetamide dimers.

Authors:  Hai-Fei Tang; Hua Zhong; Ling-Ling Zhang; Ming-Xing Gong; Shu-Qin Song; Qing-Ping Tian
Journal:  J Mol Model       Date:  2018-05-31       Impact factor: 1.810

2.  Yeast and human P4-ATPases transport glycosphingolipids using conserved structural motifs.

Authors:  Bartholomew P Roland; Tomoki Naito; Jordan T Best; Cayetana Arnaiz-Yépez; Hiroyuki Takatsu; Roger J Yu; Hye-Won Shin; Todd R Graham
Journal:  J Biol Chem       Date:  2018-12-10       Impact factor: 5.157

Review 3.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 4.  Lipid rafts in neurodegeneration and neuroprotection.

Authors:  Sandro Sonnino; Massimo Aureli; Sara Grassi; Laura Mauri; Simona Prioni; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2013-12-22       Impact factor: 5.590

Review 5.  Modeling neurodevelopmental disorders using human pluripotent stem cells.

Authors:  Michael Telias; Dalit Ben-Yosef
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

6.  Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease.

Authors:  Hila Zigdon; Alon Savidor; Yishai Levin; Anna Meshcheriakova; Raphael Schiffmann; Anthony H Futerman
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

Review 7.  Lysosomal Storage Diseases-Regulating Neurodegeneration.

Authors:  Rob U Onyenwoke; Jay E Brenman
Journal:  J Exp Neurosci       Date:  2016-04-05

Review 8.  Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases.

Authors:  Joanna Jakóbkiewicz-Banecka; Magdalena Gabig-Cimińska; Zyta Banecka-Majkutewicz; Bogdan Banecki; Alicja Węgrzyn; Grzegorz Węgrzyn
Journal:  Metab Brain Dis       Date:  2013-12-05       Impact factor: 3.584

9.  Long-term follow-up and sudden unexpected death in Gaucher disease type 3 in Egypt.

Authors:  Magy Abdelwahab; Derek Blankenship; Raphael Schiffmann
Journal:  Neurol Genet       Date:  2016-02-25

Review 10.  Neuroinflammatory paradigms in lysosomal storage diseases.

Authors:  Megan E Bosch; Tammy Kielian
Journal:  Front Neurosci       Date:  2015-10-30       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.